OIS RETINA 2023 SPEAKERS

Cariad Chester

By Jackie Wengrod | July 20, 2023

Prior to joining TCGX, Cariad was a Managing Director at Aquilo Capital, where he led investments in biotechnology companies developing human therapeutics. Prior to Aquilo…

Read More

George Lasezkay, PharmD

By Jackie Wengrod | July 5, 2023

Dr. Lasezkay has served as President and Chief Executive Officer of Clearside since March 2020, as Interim CEO from April 2019-March 2020, and has been…

Read More

Jason Jun

By Jackie Wengrod | June 30, 2023

Jason Jun is a Managing Director in the Healthcare Investment Banking Group at Citi specializing in Life Sciences, based in New York. Jason has over…

Read More

Cameron Taylor

By Jackie Wengrod | June 27, 2023

Cameron Taylor is an experienced advisor with focus on biotechnology and pharmaceutical companies. He has a strong background in the biotechnology and pharmaceutical industry, corporate…

Read More

Carlos Quezada Ruiz, MD

By Jackie Wengrod | June 15, 2023

Carlos Quezada-Ruiz, M.D. is an active clinician with 10+ years of clinical and early to late stage research experience. Currently a Group Medical Director on…

Read More

Jennifer I. Lim, MD, FARVO

By Maureen Linnemann | June 14, 2023

Jennifer I. Lim MD, FARVO, FASRS holds the Marion H. Schenk Esq., Chair in Ophthalmology for Research in the Aging Eye as UIC Distinguished Professor…

Read More

Cedric Francois, MD, PhD

By Maureen Linnemann | June 7, 2023

Cedric is a co-founder of our company and has served as a member of our board of directors and as our President and Chief Executive…

Read More

Céline Olmiere, PhD

By Maureen Linnemann | June 7, 2023

Céline Olmiere received her PhD in Molecular and cellular biology from the Claude Bernard University in Lyon, after research in virology (INSERM /Institut Pasteur) and…

Read More

Anthony Wallace

By Maureen Linnemann | June 7, 2023

Anthony is a seasoned healthcare executive who spent the last 26 years in various sales, marketing, operations, supply chain and leadership roles. Anthony has held…

Read More
Peter Francis MD PhD

Peter Francis, MD, PhD

By Maureen Linnemann | June 7, 2023

Peter Francis, MD, PhD, Chief Medical & Scientific Officer – Ray Therapeutics Peter Francis is a highly experienced biotechnology executive and an ophthalmologist clinician-scientist with…

Read More

Daniel Chung, DO

By Maureen Linnemann | June 7, 2023

Dr. Chung was appointed Chief Medical Officer of SparingVision in February 2021. In his role, he leads the clinical development and research into SPVN06, SparingVision’s…

Read More
Sun Young Lee, MD

Sun Young Lee, MD, PhD

By Maureen Linnemann | June 7, 2023

Dr. Sun Young Lee is a nationally recognized expert in 1) diagnosis and treatment of inherited retinal degenerative diseases, including retinitis pigmentosa, macular dystrophy, and…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.